OrthAlign Gets FDA Clearance on ORTHALIGN PLUS

OrthAlign has received 510(k) clearance from the U.S. Food and Drug Administration to market its ORTHALIGN PLUS system.

Advertisement

The system is a palm-sized, single-use navigation device intended for use during total hip arthroplasty and total knee arthroplasty procedures. Additionally, the company’s KNEEALIGN technology will be fully integrated into the OrthAlign Plus system.

 

OrthAlign Plus will be commercially available in fall 2014.

More Articles on Devices:

5 Key Results: LDR’s Mobi-C Artificial Disc Replacement vs. ACDF
FDA Clears AccelSPINE’s Next Generation Minimally Invasive Spine System
Global Medical Device Market to Grow at 6.2% Annually Until 2018

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

160 ambulatory leaders just ranked the EHR as the single system most overdue for AI reinvention

Tuesday, August 11
12:00 PM - 1:00 PM CDT

Presenter: Gautam Shah, MBA, FACHDM, NextGen Healthcare

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.